GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » AirSculpt Technologies Inc (NAS:AIRS) » Definitions » ROE %

AirSculpt Technologies (AirSculpt Technologies) ROE % : -21.76% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is AirSculpt Technologies ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. AirSculpt Technologies's annualized net income for the quarter that ended in Dec. 2023 was $-18.3 Mil. AirSculpt Technologies's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $84.1 Mil. Therefore, AirSculpt Technologies's annualized ROE % for the quarter that ended in Dec. 2023 was -21.76%.

The historical rank and industry rank for AirSculpt Technologies's ROE % or its related term are showing as below:

AIRS' s ROE % Range Over the Past 10 Years
Min: -19.03   Med: -1.84   Max: 10.18
Current: -5.66

During the past 5 years, AirSculpt Technologies's highest ROE % was 10.18%. The lowest was -19.03%. And the median was -1.84%.

AIRS's ROE % is ranked worse than
68.14% of 612 companies
in the Healthcare Providers & Services industry
Industry Median: 4.115 vs AIRS: -5.66

AirSculpt Technologies ROE % Historical Data

The historical data trend for AirSculpt Technologies's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AirSculpt Technologies ROE % Chart

AirSculpt Technologies Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
-1.84 6.21 10.18 -19.03 -5.79

AirSculpt Technologies Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -40.17 -0.08 9.07 -8.05 -21.76

Competitive Comparison of AirSculpt Technologies's ROE %

For the Medical Care Facilities subindustry, AirSculpt Technologies's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AirSculpt Technologies's ROE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, AirSculpt Technologies's ROE % distribution charts can be found below:

* The bar in red indicates where AirSculpt Technologies's ROE % falls into.



AirSculpt Technologies ROE % Calculation

AirSculpt Technologies's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=-4.479/( (70.766+83.992)/ 2 )
=-4.479/77.379
=-5.79 %

AirSculpt Technologies's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=-18.296/( (84.191+83.992)/ 2 )
=-18.296/84.0915
=-21.76 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


AirSculpt Technologies  (NAS:AIRS) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-18.296/84.0915
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-18.296 / 190.432)*(190.432 / 204.071)*(204.071 / 84.0915)
=Net Margin %*Asset Turnover*Equity Multiplier
=-9.61 %*0.9332*2.4268
=ROA %*Equity Multiplier
=-8.97 %*2.4268
=-21.76 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-18.296/84.0915
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-18.296 / 1.524) * (1.524 / 5.56) * (5.56 / 190.432) * (190.432 / 204.071) * (204.071 / 84.0915)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= -12.0052 * 0.2741 * 2.92 % * 0.9332 * 2.4268
=-21.76 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


AirSculpt Technologies ROE % Related Terms

Thank you for viewing the detailed overview of AirSculpt Technologies's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


AirSculpt Technologies (AirSculpt Technologies) Business Description

Traded in Other Exchanges
N/A
Address
1111 Lincoln Road, Suite 802, Miami Beach, FL, USA, 33139
AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under our brand Elite Body Sculpture. At Elite Body Sculpture, company provide custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure, producing dramatic results. Its mission is to generate the best results for patients.
Executives
Todd Magazine director, officer: President and CEO 1111 LINCOLN ROAD, SUITE 802, MIAMI BEACH FL 33139
Thomas J Aaron director 4000 MERIDIAN BOULEVARD, FRANKLIN TN 37067
Dennis Dean officer: Chief Financial Officer 40 BURTON HILLS BOULEVARD SUITE 500, NASHVILLE TN 37215
Caroline Chu director 400 ALTON ROAD, UNIT TH-103M, MIAMI BEACH FL 33139
Kenneth Higgins director 400 ALTON ROAD, UNIT TH-103M, MIAMI BEACH FL 33139
Aaron Rollins director, 10 percent owner, officer: Chief Executive Officer 400 ALTON ROAD, UNIT TH-103M, MIAMI BEACH FL 33139
Adam T Feinstein director, 10 percent owner 40 BURTON HILLS BOULEVARD SUITE 500, NASHVILLE TN 37215
Ronald P. Zelhof officer: COO and President 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Pamela L. Netzky director C/O AMPLIFY SNACK BRANDS, INC., 500 WEST 5TH STREET, AUSTIN TX 78701
Daniel Sollof director 400 ALTON ROAD, UNIT TH-103M, MIAMI BEACH FL 33139
Vscp Ebs Aggregator, L.p. director, 10 percent owner 428 GREENWICH STREET, NEW YORK NY 10013
Ebs Aggregator Blocker Holdings, Llc director, 10 percent owner 428 GREENWICH STREET, NEW YORK NY 10013